Belgium· BE-AMP-SAM324676-00

Erazaban 10 %

A docosanol product containing docosanol, registered in Belgium by Phoenix Healthcare. The same ATC class is registered in 5 of our 19 countries.

ATC D06BB11

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedErazaban 10 %ATCD06BB11REGISTER NO.BE-AMP-SAM324676-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Docosanol is registered in 5 of 19 countries.

Countries holding a registration under ATC D06BB11 (docosanol), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose

Docosanol · ATC D06BB11

5 / 19 countries

  • Belgiumprice
  • Franceprice
  • Polandprice
  • Spainprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Docosanol
Manufacturer
Phoenix Healthcare
Country
Belgium (BE)
ATC code
D06BB11
ATC class
Docosanol
Defined daily dose
50 mg, T
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    2711380

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Docosanol in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All docosanol products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Austria · Erazaban
  • France · Erazaban
  • United Kingdom (Northern Ireland) · Cold Sore, Docosanol Dendron Brands
  • Poland · Erazaban

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5f92308c-936e-4619-9cfc-5ca3e9afebf4
GET /v1/drugs/5f92308c-936e-4619-9cfc-5ca3e9afebf4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Cream",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Erazaban 10 %",
  "name_fr": "Erazaban 10 %",
  "name_nl": "Erazaban 10 %",
  "amp_code": "SAM324676-00",
  "strengths": [
    "10.0000",
    "2.7000",
    "5.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Docosanol",
    "Benzyl Alcohol",
    "Propylene Glycol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Docosanol",
  "authorisation_numbers": [
    "BE324676"
  ]
}

See everything about docosanol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.